Back to today’s briefing

Story perspectives

New Nipah Vaccine Trials Launch in Bangladesh, $17.3M Backing

7/24/2025

48 11

Summary

Story summary

A groundbreaking Nipah vaccine, PHV02, is set to begin mid-stage human trials in Bangladesh in early 2026, backed by a $17.3 million investment from CEPI. With plans to enroll 500 adults and 75 children, this vaccine offers hope for swift immunity against a deadly virus that currently has no treatments available.

1 of 1

Story summary

A groundbreaking Nipah vaccine, PHV02, is set to begin mid-stage human trials in Bangladesh in early 2026, backed by a $17.3 million investment from CEPI. With plans to enroll 500 adults and 75 children, this vaccine offers hope for swift immunity against a deadly virus that currently has no treatments available.